MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$9,746K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of investme...
Accounts payable
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of investment securiti...
Net loss
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-17,984
-18,978
-19,491
-17,838
Stock-based compensation expense
2,696
3,453
4,063
5,080
Depreciation and amortization
627
795
881
1,011
Non-cash lease expense
418
387
410
401
Non-cash interest expense
710
700
713
710
Amortization of premium on investments, net
385
413
536
689
Change in provision for inventories
-7
95
79
-43
Change in provision for credit losses
1,135
-402
2,865
-972
Loss on disposal of property and equipment
0
-
0
-3
Loss on extinguishment of term loan
0
0
0
0
Accounts receivable
5,036
-3,409
-1,768
-2,900
Inventories
-2,340
2,244
-1,492
-3,004
Prepaid expenses and other assets
-855
-932
1,300
108
Accounts payable
2,968
865
-1,129
338
Accrued compensation and related benefits
318
-1,980
-120
1,066
Accrued expenses and other current liabilities
1,323
2,166
2,735
-1,826
Accrued warranty liability
-554
-22
11
123
Deferred revenue
1,338
-1,194
-1,375
980
Operating lease liabilities
-397
-413
-587
-460
Accrued interest
0
0
0
0
Net cash used in operating activities
-9,635
-12,844
-9,521
-6,320
Purchases of property and equipment
111
65
223
160
Purchases of investment securities
18,647
22,895
28,221
40,095
Sales and maturities of investment securities
32,924
30,859
37,034
43,222
Net cash used in investing activities
14,166
7,899
8,590
2,967
Proceeds from stock option exercises and espp purchases
0
506
0
231
Payments on finance lease liabilities
88
5
-
-
Repayment of term loan and extinguishment costs
0
0
0
0
Proceeds from issuance of term loans, net of issuance costs
0
0
0
0
Proceeds from issuance of series a convertible preferred stock, net of issuance costs
0
0
0
0
Payment of deferred financing costs
-
-
0
-
Net cash provided by financing activities
-88
501
0
231
Net decrease in cash, cash equivalents and restricted cash
4,443
-4,444
-931
-3,122
Cash, cash equivalents and restricted cash as of beginning of period
34,391
38,835
39,766
127,343
Cash, cash equivalents and restricted cash as of end of period
38,834
34,391
38,835
39,766
Cash and cash equivalents
35,005
-
-
-
Restricted cash
3,829
-
-
-
Total cash, cash equivalents and restricted cash
38,834
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Sales and maturities
of investment...
$32,924K
(-26.55%↓ Y/Y)
Net cash used in
investing activities
$14,166K
(112.97%↑ Y/Y)
Canceled cashflow
$18,758K
Net decrease in
cash, cash...
$4,443K
(105.26%↑ Y/Y)
Canceled cashflow
$9,723K
Purchases of investment
securities
$18,647K
(-87.86%↓ Y/Y)
Purchases of property and
equipment
$111K
(-73.25%↓ Y/Y)
Accounts payable
$2,968K
(218.63%↑ Y/Y)
Stock-based compensation
expense
$2,696K
(-58.35%↓ Y/Y)
Inventories
-$2,340K
(67.93%↑ Y/Y)
Deferred revenue
$1,338K
(33.93%↑ Y/Y)
Accrued expenses and
other current...
$1,323K
(116.89%↑ Y/Y)
Change in provision for
credit losses
$1,135K
(-30.02%↓ Y/Y)
Prepaid expenses and
other assets
-$855K
(-82.69%↓ Y/Y)
Non-cash interest
expense
$710K
(-46.82%↓ Y/Y)
Depreciation and
amortization
$627K
(-74.40%↓ Y/Y)
Non-cash lease expense
$418K
(-45.85%↓ Y/Y)
Accrued compensation
and related...
$318K
(104.52%↑ Y/Y)
Net cash used in
operating activities
-$9,635K
(68.40%↑ Y/Y)
Net cash provided by
financing activities
-$88K
(-100.16%↓ Y/Y)
Canceled cashflow
$14,728K
Net loss
-$17,984K
(59.43%↑ Y/Y)
Payments on finance lease
liabilities
$88K
Accounts receivable
$5,036K
(463.94%↑ Y/Y)
Accrued warranty
liability
-$554K
(20.63%↑ Y/Y)
Operating lease
liabilities
-$397K
(54.16%↑ Y/Y)
Amortization of premium on
investments, net
$385K
(-62.55%↓ Y/Y)
Change in provision for
inventories
-$7K
(95.63%↑ Y/Y)
Buy us a coffee
Outset Medical, Inc. (OM)
Outset Medical, Inc. (OM)